Muhammad Hafidh Komar
Department of Digestive Surgery, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Integrating the Colon Leakage Score (CLS) and Serum Albumin to Predict Anastomotic Leakage in Colorectal Cancer Surgery: A Diagnostic Accuracy Study in an Indonesian Cohort Muhammad Rizqi Firyal; Muhammad Hafidh Komar; Theodorus
Sriwijaya Journal of Surgery Vol. 8 No. 2 (2025): Sriwijaya Journal of Surgery
Publisher : Surgery Department, Faculty of Medicine Universitas Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/sjs.v8i2.132

Abstract

Introduction: Anastomotic leakage (AL) is a devastating complication in colorectal surgery, associated with high rates of morbidity and mortality. Accurate preoperative risk stratification is essential for guiding clinical decision-making. This study aimed to evaluate the diagnostic accuracy of a synergistic model combining the clinical Colon Leakage Score (CLS) with the biochemical marker of preoperative serum albumin for predicting AL in an Indonesian patient cohort. Methods: A retrospective diagnostic accuracy study was conducted at a single tertiary care center. The study included 60 patients who underwent resection and primary anastomosis for colorectal cancer between January 2022 and June 2024. Patients who received a diverting stoma were excluded. A "high-risk" status was defined by a composite criterion: a CLS > 11 and a preoperative serum albumin level < 3.5 g/dL. The primary outcome was clinically significant AL. Following the identification of inconsistencies in the initial analysis, a complete data re-analysis was performed. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values, and overall accuracy, with 95% confidence intervals (CI), were calculated. Results: The incidence of AL was 21.7% (13/60 patients). A striking 71.7% of the cohort presented with preoperative hypoalbuminemia. The analysis revealed that the combined model demonstrated poor sensitivity of 46.2% (95% CI: 19.2% - 74.9%) but excellent specificity of 97.9% (95% CI: 88.7% - 99.9%). The model yielded a high PPV of 85.7% (95% CI: 42.1% - 99.6%) and a robust NPV of 86.8% (95% CI: 75.0% - 94.6%). The overall accuracy was 86.7%. Conclusion: The combined CLS-albumin model functions as a highly specific "rule-in" test, not a general screening tool. While it fails to identify more than half of the patients who will leak, a positive result correctly identifies a small subset of patients at extremely high risk for anastomotic leakage. The findings also highlight a profound baseline burden of malnutrition in this population, which warrants further investigation and clinical attention.
Diagnostic Accuracy of Serum Bilirubin and Magnetic Resonance Cholangiopancreatography for Differentiating Benign from Malignant Extrahepatic Obstructive Jaundice: A Histopathology-Referenced Study Muhammad Faisal; Muhammad Hafidh Komar; Theodorus
Sriwijaya Journal of Surgery Vol. 9 No. 2 (2026): Sriwijaya Journal of Surgery
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/sjs.v9i2.154

Abstract

Background: Differentiating benign from malignant extrahepatic obstructive jaundice before surgery determines whether patients are triaged towards curative or palliative treatment. Objective: To evaluate the diagnostic accuracy of serum bilirubin and magnetic resonance cholangiopancreatography (MRCP) against histopathology. Methods: This STARD-compliant, single-centre retrospective diagnostic-accuracy study included 50 consecutive adults treated at Dr. Mohammad Hoesin Central General Hospital, Palembang between January 2024 and December 2025. Serum bilirubin and MRCP were assessed against surgical or biopsy histopathology. Receiver-operating-characteristic analysis and 2×2 tables with Wilson 95% confidence intervals were computed. Results: Thirty-nine patients (78%) had benign and 11 (22%) malignant aetiology. Direct bilirubin (13.7 vs 8.7 mg/dL; p=0.003), total bilirubin (20.17 vs 13.02 mg/dL; p=0.007), and common bile duct dilation (26.0 vs 18.5 mm; p=0.018) were higher in malignancy. Direct bilirubin had an AUC of 0.797 at 9.65 mg/dL; total bilirubin had an AUC of 0.773 at 14.3 mg/dL. MRCP had 94.9% specificity, 63.6% sensitivity, and 88.0% accuracy. Conclusion: Serum bilirubin is a sensitive early rule-out marker, whereas MRCP is a highly specific confirmatory tool; their sequential use may improve pre-operative triage.